Endogenous Erythroid Colony Formation in Patients with Retinal Vein Occlusion

Ophthalmology

Volumn 114, Issue 12, 2007, Pages 2155-2161

  Héron, Emmanuel ^a   Marzac, Christophe ^b   Feldman Billard, Sylvie ^a   Girmens, Jean François ^a   Paques, Michel ^a   Delarue, Richard ^c   Piette, Jean Charles ^d   Casadevall, Nicole ^b   Hermine, Olivier ^c  

^a CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^b HÔTEL DIEU   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; JANUS KINASE 2;

ADULT; AGED; ARTICLE; BUDD CHIARI SYNDROME; CLINICAL ARTICLE; COLONY FORMATION; CULTURE MEDIUM; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ERYTHROID CELL; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; HUMAN; IN VITRO STUDY; LABORATORY TEST; MALE; MEDICAL RESEARCH; MYELOPROLIFERATIVE DISORDER; ORGAN DONOR; PATHOPHYSIOLOGY; POLYCYTHEMIA; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; VISUAL ACUITY;

ADULT; BONE MARROW; BUDD-CHIARI SYNDROME; COLONY-FORMING UNITS ASSAY; ERYTHROID CELLS; ERYTHROPOIESIS; FEMALE; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; POINT MUTATION; POLYCYTHEMIA VERA; RETINAL VEIN OCCLUSION; VISUAL ACUITY;

EID: 36549049345     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.08.014     Document Type: Article

References (50)

1. Hayreh S.S., Zimmerman M.B., and Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 117 (1994) 429-441
2. Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol 116 (1993) 286-296
3. Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 114 (1996) 545-554
4. Klein R., Klein B.E., Moss S.E., and Meuer S.M. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 98 (2000) 133-141 discussion 141-3
5. Quinlan P.M., Elman M.J., Bhatt A.K., et al. The natural course of central retinal vein occlusion. Am J Ophthalmol 110 (1990) 118-123
6. Chen J.C., Klein M.L., Watzke R.C., et al. Natural course of perfused central retinal vein occlusion. Can J Ophthalmol 30 (1995) 21-24
7. Mitchell P., Smith W., and Chang A. Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study. Arch Ophthalmol 114 (1996) 1243-1247
8. Glacet-Bernard A., Coscas G., Chabanel A., et al. Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 103 (1996) 551-560
9. Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115 (1997) 486-491
10. Arsène S., Delahousse B., Regina S., et al. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age. Thromb Haemost 94 (2005) 101-106
11. Chak M., Wallace G.R., Graham E.M., and Stanford M.R. Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease. Br J Ophthalmol 85 (2001) 883-886
12. Marcucci R., Bertini L., Giusti B., et al. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 86 (2001) 772-776
13. Janssen M.C., den Heijer M., Cruysberg J.R., et al. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis?. A meta-analysis of thrombophilic factors. Thromb Haemost 93 (2005) 1021-1026
14. Parodi M.B. Medical treatment of retinal vein occlusions. Semin Ophthalmol 19 (2004) 43-48
15. Michiels J.J., Berneman Z.N., Schroyens W., and Van Vliet H.H. Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera. Platelets 15 (2004) 67-84
16. Elliott M.A., and Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 128 (2005) 275-290
17. Berlin N.I. Diagnosis and classification of the polycythemias. Semin Hematol 12 (1975) 339-351
18. Pierre R., Imbert M., Thiele J., et al. Polycythaemia vera. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (2001), IARC Press, Lyon, France 32-34 World Health Organization Classification of Tumours
19. Westwood N.B., and Pearson T.C. Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias. Leuk Lymphoma 22 suppl (1996) 95-103
20. Menon K.V., Shah V., and Kamath P.S. The Budd-Chiari syndrome. N Engl J Med 350 (2004) 578-585
21. Juvonen E., Ikkala E., Oksanen K., and Ruutu T. Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications. Br J Haematol 83 (1993) 192-197
22. James C., Ugo V., Le Couédic J.P., et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434 (2005) 1144-1148
23. Baxter E.J., Scott L.M., Campbell P.J., et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365 (2005) 1054-1061
24. Levine R.L., Wadleigh M., Cools J., et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7 (2005) 387-397
25. Kralovics R., Passamonti F., Buser A.S., et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352 (2005) 1779-1790
26. Casadevall N., Lacombe C., and Varet B. Erythroid cultures and erythropoietin assay: clinical and diagnostic value. Nouv Rev Fr Hematol 32 (1990) 77-81
27. James C., Delhommeau F., Marzac C., et al. Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis. [letter]. Leukemia 20 (2006) 350-353
28. Reid C.D. The significance of endogenous erythroid colonies (EEC) in haematological disorders. Blood Rev 1 (1987) 133-140
29. Michiels J.J., and Juvonen E. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group. Semin Thromb Hemost 23 (1997) 339-347
30. Valla D., Casadevall N., Lacombe C., et al. Primary myeloproliferative disorder and hepatic vein thrombosis: a prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med 103 (1985) 329-334
31. De Stefano V., Teofili L., Leone G., and Michiels J.J. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 23 (1997) 411-418
32. Patel R.K., Lea N.C., Heneghan M.A., et al. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology 130 (2006) 2031-2038
33. Yoshizumi M.O., and Townsend-Pico W. Essential thrombocythemia and central retinal vein occlusion with neovascular glaucoma. Am J Ophthalmol 121 (1996) 728-730
34. Liu M., Lee A.G., Rice L., and Lambert H.M. Bilateral retinal vascular occlusive disease in essential thrombocythemia. Retina 19 (1999) 563-564
35. Imasawa M., and Iijima H. Multiple retinal vein occlusions in essential thrombocythemia. Am J Ophthalmol 133 (2002) 152-155
36. Asencio Sanchez V.M., Manteca Jimenez G., and Cano Navarro E. Essential thrombocythemia and retinal vein occlusion [in Spanish]. Arch Soc Esp Oftalmol 79 (2004) 629-632
37. Tache J.E., Saffra N., Marshak H., et al. Retinal vein thrombosis as the presenting symptom of essential thrombocythemia. Am J Med Sci 329 (2005) 139-140
38. Chim C.S., Kwong Y.L., Lie A.K., et al. Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia. Arch Intern Med 165 (2005) 2651-2658
39. Wechsler D.Z., Tay T.S., and McKay D.L. Life-threatening haematological disorders presenting with ophthalmic manifestations. Clin Experiment Ophthalmol 32 (2004) 547-550
40. D'Amato R.J., Miller N.R., Fine S.L., et al. The effect of age and initial visual acuity on the systemic and visual prognosis of central retinal vein occlusion. Aust N Z J Ophthalmol 19 (1991) 118-122
41. Recchia F.M., Carvalho-Recchia C.A., and Hassan T.S. Clinical course of younger patients with central retinal vein occlusion. Arch Ophthalmol 122 (2004) 317-321
42. Bombeli T., Basic A., and Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol 70 (2002) 126-132
43. Martinelli I. Unusual forms of venous thrombosis and thrombophilia. Pathophysiol Haemost Thromb 32 (2002) 343-345
44. Elman M.J., Bhatt A.K., Quinlan P.M., and Enger C. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology 97 (1990) 1543-1548
45. Mansour A.M., Walsh J.B., and Henkind P. Mortality and morbidity in patients with central retinal vein occlusion. Ophthalmologica 204 (1992) 199-203
46. Tsaloumas M.D., Kirwan J., Vinall H., et al. Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye 14 (2000) 821-827
47. Gruppo Italiano Studio Policitemia. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Ann Intern Med 123 (1995) 656-664
48. Green W.R., Chan C.C., Hutchins G.M., and Terry J.M. Central retinal vein occlusion: a prospective histopathological study of 29 eyes in 28 cases. Retina 1 (1981) 27-55
49. Williamson T.H. Central retinal vein occlusion: what's the story?. Br J Ophthalmol 81 (1997) 698-704
50. Browning D.J., and Fraser C.M. Retinal vein occlusions in patients taking warfarin. Ophthalmology 111 (2004) 1196-1200